Skip to main content

Akili Interactive

By Dave Muoio | 03:00 pm | January 15, 2020
Topline data released today by the digital therapeutics company also suggest that its FDA approval-pending treatment continued to deliver benefits with continued use.
By Dave Muoio | 04:22 pm | April 11, 2019
Also: AccuReg brings on a new chief marketing officer; Blink Health hires a tech industry HR vet.
By Dave Muoio | 01:05 pm | January 09, 2019
At CES 2019, the digital therapeutic company's CEO and cofounder described work on an independent prescription, procurement and support platform specific to digital medicines.
By Dave Muoio | 04:51 pm | January 03, 2019
The study's 19 young participants stuck to their regimens, and along with their parents said that they would be open to continuing treatment sessions. 
By Dave Muoio | 04:43 pm | November 26, 2018
Also: Greenway Health appoints new CISO; DocuTAP hires SVP of product, EVP of people and culture. 
By Dave Muoio | 10:59 am | August 09, 2018
Boston-based digital therapeutics company Akili Interactive Labs announced this morning that it has added an extra $13 million to its previously announced Series C financing.
By Dave Muoio | 11:05 am | May 09, 2018
This morning, Boston-based Akili Interactive Labs announced the closure of a $55 million Series C funding round.
By Laura Lovett | 03:51 pm | April 10, 2018
This week has spurred some major patent announcements from digital health companies Akili Interactive and Sonde Health, which are both affiliated with PureTech Health, a cross disciplinary biopharma company.